Author

Ching-Chu Lo

Institution: St. Martin de Porres Hospital

Observed institutions: St. Martin de Porres Hospital, National Yang Ming University

ORCID: 0000-0002-9488-6185

Observed ORCID: 0000-0002-9488-6185

OpenAlex ID: A5103520790

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

2021 · Ming-Lun Yeh, Chao-Hung Hung, et al. · Hepatology International · 12

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study

2018 · Chen-Hua Liu, Ming-Lung Yu, et al. · Journal of the Formosan Medical Association · 10

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients

2015 · Chi-Chieh Yang, Wei-Lun Tsai, et al. · PLoS ONE · 9

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry

2024 · Tyng-Yuan Jang, Chung-Feng Huang, et al. · Journal of the Formosan Medical Association · 8

Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study

2025 · Teng-Yu Lee, Sheng-Shun Yang, et al. · European Journal of Cancer · 4

Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH)

2025 · Ping-Jen Hu, Ming-Lung Yu, et al. · Journal of the Formosan Medical Association · 2

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study

2026 · Masayuki Ueno, Yung-Yeh Su, et al. · Liver Cancer

Works count: 7

Citation count: 45

H-index: 4

I10-index: 2